nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—stomach cancer	0.712	0.953	CbGaD
Auranofin—ALB—stomach cancer	0.0354	0.0474	CbGaD
Auranofin—ALB—Irinotecan—stomach cancer	0.0271	0.402	CbGbCtD
Auranofin—ALB—Fluorouracil—stomach cancer	0.026	0.386	CbGbCtD
Auranofin—ALB—Methotrexate—stomach cancer	0.0144	0.213	CbGbCtD
Auranofin—PRDX5—hematopoietic system—stomach cancer	0.00359	0.0999	CbGeAlD
Auranofin—PRDX5—epithelium—stomach cancer	0.00328	0.0913	CbGeAlD
Auranofin—PRDX5—pancreas—stomach cancer	0.00292	0.0813	CbGeAlD
Auranofin—PRDX5—lymphoid tissue—stomach cancer	0.00253	0.0703	CbGeAlD
Auranofin—PRDX5—digestive system—stomach cancer	0.00249	0.0695	CbGeAlD
Auranofin—PRDX5—bone marrow—stomach cancer	0.0023	0.064	CbGeAlD
Auranofin—ALB—gall bladder—stomach cancer	0.00219	0.061	CbGeAlD
Auranofin—IKBKB—hematopoietic system—stomach cancer	0.00212	0.0591	CbGeAlD
Auranofin—PRDX5—endocrine gland—stomach cancer	0.00206	0.0574	CbGeAlD
Auranofin—IKBKB—smooth muscle tissue—stomach cancer	0.00187	0.0521	CbGeAlD
Auranofin—PRDX5—liver—stomach cancer	0.00186	0.0517	CbGeAlD
Auranofin—IKBKB—lymphoid tissue—stomach cancer	0.0015	0.0416	CbGeAlD
Auranofin—IKBKB—digestive system—stomach cancer	0.00148	0.0411	CbGeAlD
Auranofin—PRDX5—lymph node—stomach cancer	0.00142	0.0397	CbGeAlD
Auranofin—IKBKB—endocrine gland—stomach cancer	0.00122	0.034	CbGeAlD
Auranofin—IKBKB—liver—stomach cancer	0.0011	0.0306	CbGeAlD
Auranofin—Interstitial pneumonia—Docetaxel—stomach cancer	0.000868	0.014	CcSEcCtD
Auranofin—IKBKB—lymph node—stomach cancer	0.000844	0.0235	CbGeAlD
Auranofin—Pancytopenia—Mitomycin—stomach cancer	0.000832	0.0135	CcSEcCtD
Auranofin—Alopecia—Floxuridine—stomach cancer	0.00079	0.0128	CcSEcCtD
Auranofin—Stomatitis—Mitomycin—stomach cancer	0.000762	0.0123	CcSEcCtD
Auranofin—Anaemia—Floxuridine—stomach cancer	0.000719	0.0116	CcSEcCtD
Auranofin—Leukopenia—Floxuridine—stomach cancer	0.000697	0.0113	CcSEcCtD
Auranofin—ALB—liver—stomach cancer	0.000642	0.0179	CbGeAlD
Auranofin—Interstitial pneumonia—Methotrexate—stomach cancer	0.000625	0.0101	CcSEcCtD
Auranofin—Thrombocytopenia—Floxuridine—stomach cancer	0.000622	0.0101	CcSEcCtD
Auranofin—Alopecia—Mitomycin—stomach cancer	0.00062	0.01	CcSEcCtD
Auranofin—Anorexia—Floxuridine—stomach cancer	0.000605	0.00979	CcSEcCtD
Auranofin—Interstitial lung disease—Docetaxel—stomach cancer	0.000592	0.00958	CcSEcCtD
Auranofin—Anaemia—Mitomycin—stomach cancer	0.000564	0.00912	CcSEcCtD
Auranofin—Decreased appetite—Floxuridine—stomach cancer	0.000552	0.00893	CcSEcCtD
Auranofin—Leukopenia—Mitomycin—stomach cancer	0.000547	0.00884	CcSEcCtD
Auranofin—Gastrointestinal pain—Floxuridine—stomach cancer	0.000519	0.0084	CcSEcCtD
Auranofin—Abdominal pain—Floxuridine—stomach cancer	0.000502	0.00812	CcSEcCtD
Auranofin—ALB—lymph node—stomach cancer	0.000493	0.0137	CbGeAlD
Auranofin—Thrombocytopenia—Mitomycin—stomach cancer	0.000488	0.00789	CcSEcCtD
Auranofin—Anorexia—Mitomycin—stomach cancer	0.000475	0.00768	CcSEcCtD
Auranofin—Dermatitis exfoliative—Irinotecan—stomach cancer	0.000467	0.00754	CcSEcCtD
Auranofin—Proteinuria—Capecitabine—stomach cancer	0.000462	0.00747	CcSEcCtD
Auranofin—Protein urine present—Capecitabine—stomach cancer	0.000456	0.00737	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Irinotecan—stomach cancer	0.00044	0.00712	CcSEcCtD
Auranofin—Diarrhoea—Floxuridine—stomach cancer	0.000435	0.00702	CcSEcCtD
Auranofin—Decreased appetite—Mitomycin—stomach cancer	0.000433	0.007	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—stomach cancer	0.000427	0.0069	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Fluorouracil—stomach cancer	0.000422	0.00682	CcSEcCtD
Auranofin—Vomiting—Floxuridine—stomach cancer	0.000404	0.00653	CcSEcCtD
Auranofin—Rash—Floxuridine—stomach cancer	0.0004	0.00647	CcSEcCtD
Auranofin—Dermatitis—Floxuridine—stomach cancer	0.0004	0.00647	CcSEcCtD
Auranofin—Melaena—Capecitabine—stomach cancer	0.000397	0.00641	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—stomach cancer	0.000385	0.00623	CcSEcCtD
Auranofin—Nausea—Floxuridine—stomach cancer	0.000377	0.0061	CcSEcCtD
Auranofin—Dysphagia—Fluorouracil—stomach cancer	0.000365	0.00589	CcSEcCtD
Auranofin—Eosinophilia—Fluorouracil—stomach cancer	0.000361	0.00583	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—stomach cancer	0.00036	0.00583	CcSEcCtD
Auranofin—Neutropenia—Irinotecan—stomach cancer	0.000356	0.00575	CcSEcCtD
Auranofin—Pancytopenia—Fluorouracil—stomach cancer	0.000346	0.0056	CcSEcCtD
Auranofin—Weight decreased—Irinotecan—stomach cancer	0.000344	0.00557	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—stomach cancer	0.000344	0.00556	CcSEcCtD
Auranofin—Diarrhoea—Mitomycin—stomach cancer	0.000341	0.00551	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—stomach cancer	0.000339	0.00548	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—stomach cancer	0.000333	0.00539	CcSEcCtD
Auranofin—Stomatitis—Irinotecan—stomach cancer	0.000331	0.00535	CcSEcCtD
Auranofin—Jaundice—Irinotecan—stomach cancer	0.000331	0.00535	CcSEcCtD
Auranofin—Glossitis—Methotrexate—stomach cancer	0.000328	0.0053	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—stomach cancer	0.00032	0.00517	CcSEcCtD
Auranofin—Neuropathy peripheral—Fluorouracil—stomach cancer	0.000319	0.00515	CcSEcCtD
Auranofin—Vomiting—Mitomycin—stomach cancer	0.000317	0.00512	CcSEcCtD
Auranofin—Stomatitis—Fluorouracil—stomach cancer	0.000317	0.00512	CcSEcCtD
Auranofin—Conjunctivitis—Fluorouracil—stomach cancer	0.000316	0.00511	CcSEcCtD
Auranofin—Rash—Mitomycin—stomach cancer	0.000314	0.00508	CcSEcCtD
Auranofin—Dermatitis—Mitomycin—stomach cancer	0.000314	0.00508	CcSEcCtD
Auranofin—Dermatitis exfoliative—Capecitabine—stomach cancer	0.000312	0.00505	CcSEcCtD
Auranofin—Glossitis—Epirubicin—stomach cancer	0.000307	0.00496	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.000304	0.00492	CcSEcCtD
Auranofin—Agranulocytosis—Fluorouracil—stomach cancer	0.000303	0.0049	CcSEcCtD
Auranofin—Nausea—Mitomycin—stomach cancer	0.000296	0.00479	CcSEcCtD
Auranofin—Melaena—Methotrexate—stomach cancer	0.000295	0.00477	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.000295	0.00476	CcSEcCtD
Auranofin—Visual impairment—Irinotecan—stomach cancer	0.000294	0.00475	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—stomach cancer	0.000284	0.00459	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—stomach cancer	0.000284	0.00459	CcSEcCtD
Auranofin—Melaena—Epirubicin—stomach cancer	0.000276	0.00447	CcSEcCtD
Auranofin—Alopecia—Irinotecan—stomach cancer	0.000269	0.00435	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—stomach cancer	0.000266	0.00429	CcSEcCtD
Auranofin—Dysphagia—Docetaxel—stomach cancer	0.000263	0.00425	CcSEcCtD
Auranofin—Flatulence—Irinotecan—stomach cancer	0.000261	0.00422	CcSEcCtD
Auranofin—Alopecia—Fluorouracil—stomach cancer	0.000258	0.00417	CcSEcCtD
Auranofin—Melaena—Doxorubicin—stomach cancer	0.000256	0.00413	CcSEcCtD
Auranofin—Dysphagia—Capecitabine—stomach cancer	0.000255	0.00412	CcSEcCtD
Auranofin—Pancytopenia—Docetaxel—stomach cancer	0.00025	0.00404	CcSEcCtD
Auranofin—Neutropenia—Docetaxel—stomach cancer	0.000246	0.00398	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—stomach cancer	0.000246	0.00397	CcSEcCtD
Auranofin—Anaemia—Irinotecan—stomach cancer	0.000245	0.00396	CcSEcCtD
Auranofin—Pancytopenia—Capecitabine—stomach cancer	0.000242	0.00391	CcSEcCtD
Auranofin—Neutropenia—Capecitabine—stomach cancer	0.000238	0.00385	CcSEcCtD
Auranofin—Weight decreased—Docetaxel—stomach cancer	0.000238	0.00385	CcSEcCtD
Auranofin—Leukopenia—Irinotecan—stomach cancer	0.000237	0.00384	CcSEcCtD
Auranofin—Anaemia—Fluorouracil—stomach cancer	0.000235	0.0038	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—stomach cancer	0.000233	0.00376	CcSEcCtD
Auranofin—Weight decreased—Capecitabine—stomach cancer	0.00023	0.00373	CcSEcCtD
Auranofin—Neuropathy peripheral—Docetaxel—stomach cancer	0.00023	0.00372	CcSEcCtD
Auranofin—Stomatitis—Docetaxel—stomach cancer	0.000229	0.0037	CcSEcCtD
Auranofin—Jaundice—Docetaxel—stomach cancer	0.000229	0.0037	CcSEcCtD
Auranofin—Conjunctivitis—Docetaxel—stomach cancer	0.000228	0.00369	CcSEcCtD
Auranofin—Leukopenia—Fluorouracil—stomach cancer	0.000227	0.00368	CcSEcCtD
Auranofin—Neuropathy peripheral—Capecitabine—stomach cancer	0.000223	0.0036	CcSEcCtD
Auranofin—Stomatitis—Capecitabine—stomach cancer	0.000221	0.00358	CcSEcCtD
Auranofin—Jaundice—Capecitabine—stomach cancer	0.000221	0.00358	CcSEcCtD
Auranofin—Conjunctivitis—Capecitabine—stomach cancer	0.000221	0.00357	CcSEcCtD
Auranofin—Agranulocytosis—Docetaxel—stomach cancer	0.000219	0.00354	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—stomach cancer	0.000218	0.00352	CcSEcCtD
Auranofin—Haematuria—Capecitabine—stomach cancer	0.000217	0.0035	CcSEcCtD
Auranofin—Agranulocytosis—Capecitabine—stomach cancer	0.000212	0.00343	CcSEcCtD
Auranofin—Thrombocytopenia—Irinotecan—stomach cancer	0.000212	0.00343	CcSEcCtD
Auranofin—Anorexia—Irinotecan—stomach cancer	0.000206	0.00334	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.000205	0.00332	CcSEcCtD
Auranofin—Thrombocytopenia—Fluorouracil—stomach cancer	0.000203	0.00328	CcSEcCtD
Auranofin—Visual impairment—Docetaxel—stomach cancer	0.000203	0.00328	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.000201	0.00325	CcSEcCtD
Auranofin—Anorexia—Fluorouracil—stomach cancer	0.000198	0.00319	CcSEcCtD
Auranofin—Eye disorder—Docetaxel—stomach cancer	0.000197	0.00318	CcSEcCtD
Auranofin—Visual impairment—Capecitabine—stomach cancer	0.000196	0.00318	CcSEcCtD
Auranofin—Eye disorder—Capecitabine—stomach cancer	0.000191	0.00308	CcSEcCtD
Auranofin—Dyspepsia—Irinotecan—stomach cancer	0.000191	0.00308	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.00019	0.00307	CcSEcCtD
Auranofin—Decreased appetite—Irinotecan—stomach cancer	0.000188	0.00304	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—stomach cancer	0.000188	0.00304	CcSEcCtD
Auranofin—Alopecia—Docetaxel—stomach cancer	0.000186	0.00301	CcSEcCtD
Auranofin—Constipation—Irinotecan—stomach cancer	0.000185	0.00299	CcSEcCtD
Auranofin—Dyspepsia—Fluorouracil—stomach cancer	0.000182	0.00295	CcSEcCtD
Auranofin—Decreased appetite—Fluorouracil—stomach cancer	0.00018	0.00291	CcSEcCtD
Auranofin—Alopecia—Capecitabine—stomach cancer	0.00018	0.00291	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—stomach cancer	0.00018	0.00291	CcSEcCtD
Auranofin—Dysgeusia—Docetaxel—stomach cancer	0.00018	0.0029	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—stomach cancer	0.000177	0.00287	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—stomach cancer	0.000177	0.00287	CcSEcCtD
Auranofin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000177	0.00286	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—stomach cancer	0.000176	0.00284	CcSEcCtD
Auranofin—Flatulence—Capecitabine—stomach cancer	0.000175	0.00283	CcSEcCtD
Auranofin—Dysgeusia—Capecitabine—stomach cancer	0.000174	0.00281	CcSEcCtD
Auranofin—Abdominal pain—Irinotecan—stomach cancer	0.000171	0.00277	CcSEcCtD
Auranofin—Anaemia—Docetaxel—stomach cancer	0.000169	0.00274	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—stomach cancer	0.000169	0.00272	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—stomach cancer	0.000166	0.00268	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—stomach cancer	0.000165	0.00266	CcSEcCtD
Auranofin—Urticaria—Fluorouracil—stomach cancer	0.000165	0.00266	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—stomach cancer	0.000164	0.00266	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—stomach cancer	0.000164	0.00265	CcSEcCtD
Auranofin—Leukopenia—Docetaxel—stomach cancer	0.000164	0.00265	CcSEcCtD
Auranofin—Anaemia—Capecitabine—stomach cancer	0.000164	0.00265	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—stomach cancer	0.000163	0.00263	CcSEcCtD
Auranofin—Haematuria—Methotrexate—stomach cancer	0.000161	0.00261	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—stomach cancer	0.000161	0.0026	CcSEcCtD
Auranofin—Leukopenia—Capecitabine—stomach cancer	0.000159	0.00257	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—stomach cancer	0.000158	0.00255	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—stomach cancer	0.000156	0.00252	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—stomach cancer	0.000155	0.00251	CcSEcCtD
Auranofin—Jaundice—Epirubicin—stomach cancer	0.000154	0.00249	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—stomach cancer	0.000154	0.00249	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—stomach cancer	0.000154	0.00249	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—stomach cancer	0.000154	0.00248	CcSEcCtD
Auranofin—Haematuria—Epirubicin—stomach cancer	0.000151	0.00244	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—stomach cancer	0.000149	0.0024	CcSEcCtD
Auranofin—Diarrhoea—Irinotecan—stomach cancer	0.000148	0.00239	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—stomach cancer	0.000148	0.00239	CcSEcCtD
Auranofin—Pruritus—Fluorouracil—stomach cancer	0.000147	0.00237	CcSEcCtD
Auranofin—Thrombocytopenia—Docetaxel—stomach cancer	0.000146	0.00237	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—stomach cancer	0.000146	0.00236	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000144	0.00232	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—stomach cancer	0.000143	0.00231	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—stomach cancer	0.000143	0.00231	CcSEcCtD
Auranofin—Anorexia—Docetaxel—stomach cancer	0.000143	0.00231	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—stomach cancer	0.000142	0.0023	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—stomach cancer	0.000142	0.00229	CcSEcCtD
Auranofin—Diarrhoea—Fluorouracil—stomach cancer	0.000142	0.00229	CcSEcCtD
Auranofin—Thrombocytopenia—Capecitabine—stomach cancer	0.000142	0.00229	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—stomach cancer	0.00014	0.00226	CcSEcCtD
Auranofin—Anorexia—Capecitabine—stomach cancer	0.000138	0.00223	CcSEcCtD
Auranofin—Vomiting—Irinotecan—stomach cancer	0.000138	0.00222	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—stomach cancer	0.000137	0.00221	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—stomach cancer	0.000137	0.00221	CcSEcCtD
Auranofin—Rash—Irinotecan—stomach cancer	0.000136	0.00221	CcSEcCtD
Auranofin—Dermatitis—Irinotecan—stomach cancer	0.000136	0.0022	CcSEcCtD
Auranofin—Alopecia—Methotrexate—stomach cancer	0.000134	0.00217	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—stomach cancer	0.000133	0.00215	CcSEcCtD
Auranofin—Vomiting—Fluorouracil—stomach cancer	0.000132	0.00213	CcSEcCtD
Auranofin—Dyspepsia—Docetaxel—stomach cancer	0.000132	0.00213	CcSEcCtD
Auranofin—Rash—Fluorouracil—stomach cancer	0.000131	0.00211	CcSEcCtD
Auranofin—Dermatitis—Fluorouracil—stomach cancer	0.000131	0.00211	CcSEcCtD
Auranofin—Decreased appetite—Docetaxel—stomach cancer	0.00013	0.0021	CcSEcCtD
Auranofin—Dysgeusia—Methotrexate—stomach cancer	0.000129	0.00209	CcSEcCtD
Auranofin—Nausea—Irinotecan—stomach cancer	0.000129	0.00208	CcSEcCtD
Auranofin—Constipation—Docetaxel—stomach cancer	0.000128	0.00207	CcSEcCtD
Auranofin—Dyspepsia—Capecitabine—stomach cancer	0.000128	0.00206	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—stomach cancer	0.000127	0.00205	CcSEcCtD
Auranofin—Decreased appetite—Capecitabine—stomach cancer	0.000126	0.00204	CcSEcCtD
Auranofin—Alopecia—Epirubicin—stomach cancer	0.000126	0.00203	CcSEcCtD
Auranofin—Constipation—Capecitabine—stomach cancer	0.000124	0.002	CcSEcCtD
Auranofin—Nausea—Fluorouracil—stomach cancer	0.000123	0.00199	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—stomach cancer	0.000123	0.00199	CcSEcCtD
Auranofin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000122	0.00198	CcSEcCtD
Auranofin—Anaemia—Methotrexate—stomach cancer	0.000122	0.00197	CcSEcCtD
Auranofin—Flatulence—Epirubicin—stomach cancer	0.000122	0.00197	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—stomach cancer	0.000121	0.00196	CcSEcCtD
Auranofin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000118	0.00191	CcSEcCtD
Auranofin—Abdominal pain—Docetaxel—stomach cancer	0.000118	0.00191	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—stomach cancer	0.000118	0.00191	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—stomach cancer	0.000116	0.00188	CcSEcCtD
Auranofin—Urticaria—Capecitabine—stomach cancer	0.000115	0.00186	CcSEcCtD
Auranofin—Abdominal pain—Capecitabine—stomach cancer	0.000115	0.00185	CcSEcCtD
Auranofin—Anaemia—Epirubicin—stomach cancer	0.000114	0.00185	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—stomach cancer	0.000113	0.00182	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—stomach cancer	0.000112	0.00181	CcSEcCtD
Auranofin—Leukopenia—Epirubicin—stomach cancer	0.000111	0.00179	CcSEcCtD
Auranofin—Pruritus—Docetaxel—stomach cancer	0.000106	0.00171	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—stomach cancer	0.000106	0.00171	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—stomach cancer	0.000106	0.00171	CcSEcCtD
Auranofin—Anorexia—Methotrexate—stomach cancer	0.000103	0.00166	CcSEcCtD
Auranofin—Pruritus—Capecitabine—stomach cancer	0.000102	0.00166	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—stomach cancer	0.000102	0.00166	CcSEcCtD
Auranofin—Diarrhoea—Docetaxel—stomach cancer	0.000102	0.00165	CcSEcCtD
Auranofin—Diarrhoea—Capecitabine—stomach cancer	9.91e-05	0.0016	CcSEcCtD
Auranofin—Thrombocytopenia—Epirubicin—stomach cancer	9.88e-05	0.0016	CcSEcCtD
Auranofin—Anorexia—Epirubicin—stomach cancer	9.62e-05	0.00156	CcSEcCtD
Auranofin—Vomiting—Docetaxel—stomach cancer	9.51e-05	0.00154	CcSEcCtD
Auranofin—Dyspepsia—Methotrexate—stomach cancer	9.49e-05	0.00153	CcSEcCtD
Auranofin—Rash—Docetaxel—stomach cancer	9.43e-05	0.00153	CcSEcCtD
Auranofin—Dermatitis—Docetaxel—stomach cancer	9.42e-05	0.00152	CcSEcCtD
Auranofin—Decreased appetite—Methotrexate—stomach cancer	9.37e-05	0.00152	CcSEcCtD
Auranofin—Vomiting—Capecitabine—stomach cancer	9.21e-05	0.00149	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—stomach cancer	9.14e-05	0.00148	CcSEcCtD
Auranofin—Rash—Capecitabine—stomach cancer	9.13e-05	0.00148	CcSEcCtD
Auranofin—Dermatitis—Capecitabine—stomach cancer	9.12e-05	0.00148	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—stomach cancer	8.9e-05	0.00144	CcSEcCtD
Auranofin—Nausea—Docetaxel—stomach cancer	8.89e-05	0.00144	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—stomach cancer	8.88e-05	0.00144	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—stomach cancer	8.82e-05	0.00143	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—stomach cancer	8.77e-05	0.00142	CcSEcCtD
Auranofin—Constipation—Epirubicin—stomach cancer	8.63e-05	0.0014	CcSEcCtD
Auranofin—Nausea—Capecitabine—stomach cancer	8.6e-05	0.00139	CcSEcCtD
Auranofin—Urticaria—Methotrexate—stomach cancer	8.57e-05	0.00138	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—stomach cancer	8.52e-05	0.00138	CcSEcCtD
Auranofin—Gastrointestinal pain—Epirubicin—stomach cancer	8.25e-05	0.00133	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—stomach cancer	8.22e-05	0.00133	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—stomach cancer	8.12e-05	0.00131	CcSEcCtD
Auranofin—Urticaria—Epirubicin—stomach cancer	8.02e-05	0.0013	CcSEcCtD
Auranofin—Constipation—Doxorubicin—stomach cancer	7.98e-05	0.00129	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—stomach cancer	7.98e-05	0.00129	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—stomach cancer	7.64e-05	0.00123	CcSEcCtD
Auranofin—Pruritus—Methotrexate—stomach cancer	7.63e-05	0.00123	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—stomach cancer	7.42e-05	0.0012	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—stomach cancer	7.38e-05	0.00119	CcSEcCtD
Auranofin—Diarrhoea—Methotrexate—stomach cancer	7.38e-05	0.00119	CcSEcCtD
Auranofin—Pruritus—Epirubicin—stomach cancer	7.14e-05	0.00115	CcSEcCtD
Auranofin—Diarrhoea—Epirubicin—stomach cancer	6.9e-05	0.00112	CcSEcCtD
Auranofin—Vomiting—Methotrexate—stomach cancer	6.86e-05	0.00111	CcSEcCtD
Auranofin—Rash—Methotrexate—stomach cancer	6.8e-05	0.0011	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—stomach cancer	6.79e-05	0.0011	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—stomach cancer	6.61e-05	0.00107	CcSEcCtD
Auranofin—Vomiting—Epirubicin—stomach cancer	6.42e-05	0.00104	CcSEcCtD
Auranofin—Nausea—Methotrexate—stomach cancer	6.4e-05	0.00104	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—stomach cancer	6.39e-05	0.00103	CcSEcCtD
Auranofin—Rash—Epirubicin—stomach cancer	6.36e-05	0.00103	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—stomach cancer	6.36e-05	0.00103	CcSEcCtD
Auranofin—Nausea—Epirubicin—stomach cancer	5.99e-05	0.000969	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—stomach cancer	5.94e-05	0.00096	CcSEcCtD
Auranofin—Rash—Doxorubicin—stomach cancer	5.89e-05	0.000952	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—stomach cancer	5.88e-05	0.000951	CcSEcCtD
Auranofin—Nausea—Doxorubicin—stomach cancer	5.55e-05	0.000897	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK3—stomach cancer	2.78e-05	0.000318	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSL—stomach cancer	2.77e-05	0.000317	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—stomach cancer	2.77e-05	0.000316	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK1—stomach cancer	2.75e-05	0.000315	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—stomach cancer	2.75e-05	0.000315	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PPP2R1A—stomach cancer	2.74e-05	0.000313	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—stomach cancer	2.73e-05	0.000313	CbGpPWpGaD
Auranofin—ALB—Metabolism—IDH3B—stomach cancer	2.73e-05	0.000312	CbGpPWpGaD
Auranofin—ALB—Metabolism—SUCLG1—stomach cancer	2.73e-05	0.000312	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MALT1—stomach cancer	2.7e-05	0.000309	CbGpPWpGaD
Auranofin—IKBKB—Immune System—LGALS3—stomach cancer	2.68e-05	0.000306	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PPIA—stomach cancer	2.65e-05	0.000304	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK1—stomach cancer	2.64e-05	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—stomach cancer	2.64e-05	0.000302	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—stomach cancer	2.62e-05	0.0003	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—stomach cancer	2.61e-05	0.000299	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—stomach cancer	2.6e-05	0.000298	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—stomach cancer	2.6e-05	0.000297	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WIF1—stomach cancer	2.58e-05	0.000295	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRH4—stomach cancer	2.58e-05	0.000295	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—stomach cancer	2.58e-05	0.000295	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINA1—stomach cancer	2.56e-05	0.000293	CbGpPWpGaD
Auranofin—ALB—Metabolism—NDUFV1—stomach cancer	2.53e-05	0.00029	CbGpPWpGaD
Auranofin—ALB—Metabolism—NDUFS1—stomach cancer	2.53e-05	0.00029	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FYN—stomach cancer	2.51e-05	0.000287	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—stomach cancer	2.5e-05	0.000286	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—stomach cancer	2.49e-05	0.000285	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—stomach cancer	2.48e-05	0.000284	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.48e-05	0.000283	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—stomach cancer	2.46e-05	0.000282	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—stomach cancer	2.44e-05	0.00028	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—stomach cancer	2.43e-05	0.000278	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FYN—stomach cancer	2.41e-05	0.000276	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1B—stomach cancer	2.4e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—stomach cancer	2.4e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—stomach cancer	2.4e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKAB1—stomach cancer	2.38e-05	0.000273	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—APOA1—stomach cancer	2.38e-05	0.000272	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—stomach cancer	2.36e-05	0.00027	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGFR2—stomach cancer	2.36e-05	0.00027	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—stomach cancer	2.32e-05	0.000266	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SPARC—stomach cancer	2.31e-05	0.000265	CbGpPWpGaD
Auranofin—ALB—Hemostasis—F2R—stomach cancer	2.31e-05	0.000265	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—stomach cancer	2.31e-05	0.000264	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—stomach cancer	2.31e-05	0.000264	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KISS1—stomach cancer	2.3e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RNF43—stomach cancer	2.3e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—stomach cancer	2.3e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—stomach cancer	2.29e-05	0.000262	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	2.27e-05	0.00026	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGFR2—stomach cancer	2.26e-05	0.000259	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IRF1—stomach cancer	2.26e-05	0.000259	CbGpPWpGaD
Auranofin—ALB—Metabolism—PGLS—stomach cancer	2.26e-05	0.000258	CbGpPWpGaD
Auranofin—ALB—Metabolism—BLVRB—stomach cancer	2.26e-05	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRF1—stomach cancer	2.25e-05	0.000257	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—stomach cancer	2.22e-05	0.000254	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1A—stomach cancer	2.22e-05	0.000254	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—stomach cancer	2.17e-05	0.000248	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS2—stomach cancer	2.16e-05	0.000247	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPAP2A—stomach cancer	2.15e-05	0.000246	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—stomach cancer	2.12e-05	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—stomach cancer	2.12e-05	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1RN—stomach cancer	2.09e-05	0.000239	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS2—stomach cancer	2.07e-05	0.000237	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.07e-05	0.000237	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FST—stomach cancer	2.05e-05	0.000235	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—stomach cancer	2.03e-05	0.000232	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—stomach cancer	2.01e-05	0.00023	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6ST—stomach cancer	1.98e-05	0.000227	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAST—stomach cancer	1.98e-05	0.000226	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RGS2—stomach cancer	1.98e-05	0.000226	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—stomach cancer	1.98e-05	0.000226	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CD44—stomach cancer	1.97e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—stomach cancer	1.96e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD44—stomach cancer	1.95e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK3—stomach cancer	1.92e-05	0.00022	CbGpPWpGaD
Auranofin—ALB—Metabolism—FBP1—stomach cancer	1.92e-05	0.00022	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA1—stomach cancer	1.92e-05	0.00022	CbGpPWpGaD
Auranofin—ALB—Metabolism—CKB—stomach cancer	1.92e-05	0.00022	CbGpPWpGaD
Auranofin—ALB—Metabolism—NDUFA2—stomach cancer	1.92e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PRKCB—stomach cancer	1.91e-05	0.000219	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK3—stomach cancer	1.89e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	1.89e-05	0.000216	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGG—stomach cancer	1.88e-05	0.000215	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—stomach cancer	1.88e-05	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HBEGF—stomach cancer	1.83e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK1—stomach cancer	1.83e-05	0.000209	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	1.82e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKAA1—stomach cancer	1.81e-05	0.000207	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLIN2—stomach cancer	1.81e-05	0.000206	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK1—stomach cancer	1.8e-05	0.000206	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—stomach cancer	1.8e-05	0.000206	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—stomach cancer	1.78e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6R—stomach cancer	1.77e-05	0.000202	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA2—stomach cancer	1.76e-05	0.000201	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RBP4—stomach cancer	1.74e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—stomach cancer	1.73e-05	0.000198	CbGpPWpGaD
Auranofin—ALB—Metabolism—PGAM1—stomach cancer	1.71e-05	0.000196	CbGpPWpGaD
Auranofin—ALB—Metabolism—NT5E—stomach cancer	1.71e-05	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—stomach cancer	1.7e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—stomach cancer	1.68e-05	0.000193	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PPP2R1A—stomach cancer	1.67e-05	0.000191	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PPP2R1A—stomach cancer	1.66e-05	0.00019	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDH7A1—stomach cancer	1.63e-05	0.000187	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLCE1—stomach cancer	1.63e-05	0.000187	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—stomach cancer	1.59e-05	0.000182	CbGpPWpGaD
Auranofin—ALB—Metabolism—UMPS—stomach cancer	1.57e-05	0.000179	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—stomach cancer	1.56e-05	0.000179	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HSPB1—stomach cancer	1.5e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGTR2—stomach cancer	1.5e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BMP2—stomach cancer	1.48e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—F2R—stomach cancer	1.48e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—stomach cancer	1.48e-05	0.000169	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FYN—stomach cancer	1.47e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—stomach cancer	1.47e-05	0.000168	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FYN—stomach cancer	1.46e-05	0.000167	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C3—stomach cancer	1.46e-05	0.000167	CbGpPWpGaD
Auranofin—ALB—Metabolism—ECHS1—stomach cancer	1.46e-05	0.000166	CbGpPWpGaD
Auranofin—ALB—Metabolism—PDHA1—stomach cancer	1.46e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—stomach cancer	1.44e-05	0.000165	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR1A—stomach cancer	1.44e-05	0.000165	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—stomach cancer	1.42e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—stomach cancer	1.41e-05	0.000161	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.4e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ANXA1—stomach cancer	1.39e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—stomach cancer	1.38e-05	0.000158	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR2—stomach cancer	1.37e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—stomach cancer	1.37e-05	0.000157	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMP—stomach cancer	1.37e-05	0.000156	CbGpPWpGaD
Auranofin—ALB—Metabolism—FADS1—stomach cancer	1.37e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB1—stomach cancer	1.35e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—stomach cancer	1.32e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—stomach cancer	1.31e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.3e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RPS6—stomach cancer	1.29e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Metabolism—SREBF2—stomach cancer	1.28e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Metabolism—RORA—stomach cancer	1.27e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—stomach cancer	1.27e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAU—stomach cancer	1.26e-05	0.000144	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS2—stomach cancer	1.26e-05	0.000144	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—stomach cancer	1.23e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAV1—stomach cancer	1.23e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.23e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOA1—stomach cancer	1.23e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—stomach cancer	1.21e-05	0.000139	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDOB—stomach cancer	1.19e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HBEGF—stomach cancer	1.19e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCB—stomach cancer	1.17e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.17e-05	0.000134	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCB—stomach cancer	1.16e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6ST—stomach cancer	1.16e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.12e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.12e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX5—stomach cancer	1.1e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB2—stomach cancer	1.09e-05	0.000125	CbGpPWpGaD
Auranofin—ALB—Metabolism—DPYD—stomach cancer	1.08e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—stomach cancer	1.08e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP2R1A—stomach cancer	1.07e-05	0.000123	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.06e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—stomach cancer	1.03e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6R—stomach cancer	1.03e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK1—stomach cancer	1.03e-05	0.000117	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—stomach cancer	1.03e-05	0.000117	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—stomach cancer	1.02e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.01e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMAD4—stomach cancer	9.96e-06	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—stomach cancer	9.85e-06	0.000113	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.83e-06	0.000112	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—stomach cancer	9.73e-06	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—stomach cancer	9.69e-06	0.000111	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—stomach cancer	9.59e-06	0.00011	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2A6—stomach cancer	9.48e-06	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FYN—stomach cancer	9.46e-06	0.000108	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RHOA—stomach cancer	9.39e-06	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—stomach cancer	9.31e-06	0.000106	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—stomach cancer	9.29e-06	0.000106	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C3—stomach cancer	9.23e-06	0.000106	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO1—stomach cancer	8.99e-06	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—stomach cancer	8.91e-06	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR2—stomach cancer	8.88e-06	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—stomach cancer	8.62e-06	9.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—stomach cancer	8.55e-06	9.78e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—stomach cancer	8.24e-06	9.42e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS2—stomach cancer	8.13e-06	9.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—stomach cancer	7.98e-06	9.13e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD44—stomach cancer	7.97e-06	9.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—stomach cancer	7.91e-06	9.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—stomach cancer	7.89e-06	9.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CAV1—stomach cancer	7.88e-06	9.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA1—stomach cancer	7.86e-06	8.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—stomach cancer	7.84e-06	8.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.74e-06	8.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—stomach cancer	7.6e-06	8.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCB—stomach cancer	7.5e-06	8.58e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6ST—stomach cancer	7.47e-06	8.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—stomach cancer	7.37e-06	8.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—stomach cancer	7.19e-06	8.23e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—stomach cancer	7.18e-06	8.21e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPP2R1A—stomach cancer	6.78e-06	7.75e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—stomach cancer	6.69e-06	7.66e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6R—stomach cancer	6.67e-06	7.62e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—stomach cancer	6.65e-06	7.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—stomach cancer	6.58e-06	7.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—stomach cancer	6.56e-06	7.5e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—stomach cancer	6.33e-06	7.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—stomach cancer	6.28e-06	7.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—stomach cancer	6.24e-06	7.14e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMS—stomach cancer	6.18e-06	7.07e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—stomach cancer	6.11e-06	6.99e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK1—stomach cancer	6.02e-06	6.89e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RHOA—stomach cancer	6.02e-06	6.89e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK1—stomach cancer	5.98e-06	6.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—stomach cancer	5.98e-06	6.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—stomach cancer	5.96e-06	6.82e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ERCC2—stomach cancer	5.75e-06	6.57e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—stomach cancer	5.69e-06	6.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—stomach cancer	5.65e-06	6.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—stomach cancer	5.57e-06	6.38e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—stomach cancer	5.4e-06	6.18e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—stomach cancer	5.29e-06	6.05e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—stomach cancer	5.23e-06	5.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—stomach cancer	5.19e-06	5.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—stomach cancer	5.16e-06	5.9e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—stomach cancer	5.06e-06	5.78e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAV1—stomach cancer	4.98e-06	5.7e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA1—stomach cancer	4.97e-06	5.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—stomach cancer	4.92e-06	5.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—stomach cancer	4.91e-06	5.62e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—stomach cancer	4.84e-06	5.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—stomach cancer	4.8e-06	5.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—stomach cancer	4.78e-06	5.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—stomach cancer	4.76e-06	5.45e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.76e-06	5.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—stomach cancer	4.65e-06	5.32e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—stomach cancer	4.59e-06	5.25e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—stomach cancer	4.38e-06	5.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—stomach cancer	4.29e-06	4.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—stomach cancer	4.25e-06	4.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—stomach cancer	4.06e-06	4.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—stomach cancer	3.95e-06	4.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK1—stomach cancer	3.86e-06	4.42e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—stomach cancer	3.86e-06	4.42e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—stomach cancer	3.77e-06	4.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—stomach cancer	3.65e-06	4.17e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—stomach cancer	3.45e-06	3.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—stomach cancer	3.35e-06	3.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—stomach cancer	3.24e-06	3.71e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—stomach cancer	3.1e-06	3.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—stomach cancer	2.97e-06	3.4e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—stomach cancer	2.12e-06	2.42e-05	CbGpPWpGaD
